ThitareeSarmkasat/iStock via Getty Images
Cortexyme’s hypothesis is that a neurological infection with P. gingivalis (Pg) is a cause of Alzheimer’s disease (AD). The GAIN trial enrolled mild to moderate Alzheimer’s patients but required no proof that patients…
Cortexyme: A Challenging Path Forward
Share this article
More News

Gemini Says Crypto Downturn Sank Stock Post-IPO, Not Fraud
October 22, 2026



(SVA) Technical Analysis and Trading Signals
October 22, 2026
France AMF Proposes MiCA Reforms for Stablecoins, Crypto and DeFi
October 22, 2026

